Watch These Hot Ones: AptarGroup, Inc., Resolute Forest Products (NYSE:RFP), Arcadia Biosciences (NASDAQ:RKDA), Exterran Partners, L.P. (NASDAQ:EXLP)

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) shares fell -5.55% in last trading session and ended the day at $18.90. AERI has a return on assets of -37.20%. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) quarterly performance is 8.06%.

On2 4 September, Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), announced that on September 23, dosing commenced of the first patients enrolled in Rocket 4, the Company’s fourth Phase 3 clinical trial of RhopressaTM, a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. Aerie anticipates total enrollment of approximately 700 patients in this two-arm 90-day efficacy study, comparing once-daily RhopressaTM for non-inferiority to twice daily timolol.

AptarGroup, Inc. (NYSE:ATR) ended the last trading day at $67.68. Company weekly volatility is calculated as 1.95% and price to cash ratio as 9.27. AptarGroup, Inc. (NYSE:ATR) showed a weekly performance of 4.22%.

AptarGroup Inc. (NYSE:ATR) plans to report its 2015 third quarter results after trading on the New York Stock Exchange has closed on Thursday, October 29, 2015. AptarGroup will hold a conference call on Friday, October 30, 2015, at 8:00 a.m. CDT (9:00 a.m. EDT) to discuss the third quarter results.

On 06 October, Resolute Forest Products Inc. (NYSE:RFP) shares increased 0.64% and was closed at $9.50. RFP EPS growth in last 5 year was 35.80%. Resolute Forest Products Inc. (NYSE:RFP) year to date (YTD) performance is -46.05%.

Arcadia Biosciences, Inc. (NASDAQ:RKDA) shares fell -7.41% in last trading session and ended the day at $3.00. RKDA Gross Margin is 69.20% and its has a return on assets of -63.20%. Arcadia Biosciences, Inc. (NASDAQ:RKDA) quarterly performance is -53.20%.

Arcadia Biosciences Inc. (NASDAQ:RKDA) announced that its joint venture with Bioceres S.A., Verdeca, has received approval of its HB4 stress tolerance trait in soybeans by Argentina’s Ministry of Agriculture, Livestock and Fisheries. The President of Argentina, Cristina Fernández de Kirchner, made the official announcement on Monday at a special event broadcasted nationwide. Verdeca’s completion of the regulatory process in Argentina for HB4 stress tolerant soybeans is the world’s first for an abiotic stress tolerance trait in this crop.

Exterran Partners, L.P. (NASDAQ:EXLP) caters to the Basic Materials space. It has a net profit margin of 9.70% and weekly performance is 18.34%. On the last day of trading company shares ended up at $18.00. Exterran Partners, L.P. (NASDAQ:EXLP) distance from 50-day simple moving average (SMA50) is -4.90%.

Credit Suisse reiterated their neutral rating on shares of Exterran Partners, L.P. (NASDAQ:EXLP) in a research note issued to investors on Friday, MarketBeat reports.